Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingwei Zhao

Showing results (231-240 of 247) with videos related to

Pageof 25
Sort By:
Journal of Clinical Microbiology|July 24, 2015
Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in StoolLinan Song, Mingwei Zhao, David C Duffy, et al.
BMC Ophthalmology|January 3, 2025
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centersYusheng Zhong, Xiacheng Lin, Yating Yang, et al.
The American Journal of Pathology|May 22, 2021
Human RGR Gene and Associated Features of Age-Related Macular Degeneration in Models of Retina-Choriocapillaris AtrophyXuan Bao, Zhaoxia Zhang, Yanjiang Guo, et al.
International Journal of Retina and Vitreous|June 26, 2026
Intravitreal aflibercept 8 mg in patients with neovascular age-related macular degeneration from China: 48-week results from the PULSAR trialXiaodong Sun, Hong Dai, Youxin Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2019
Toxin A-Predominant Pathogenic Clostridioides difficile: A Novel Clinical PhenotypeQianyun Lin, Nira R Pollock, Alice Banz, et al.
Investigative Ophthalmology & Visual Science|September 12, 2022
UBE3D Is Involved in Blue Light-Induced Retinal Damage by Regulating Double-Strand Break RepairNingda Xu, Yue Liu, Shanshan Nai, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|December 17, 2022
More light components and less light damage on rats' eyes: evidence for the photobiomodulation and spectral opponencyJingxin Nie, Ningda Xu, Zhizhong Chen, et al.
Frontiers in Molecular Biosciences|June 27, 2022
Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in AsiansZongyi Wang, Jiyang Tang, Enzhong Jin, et al.
The British Journal of Ophthalmology|December 25, 2025
Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trialsShuo Zhao, Miaoqin Wu, Jingxiang Zhong, et al.
JAMA Ophthalmology|January 3, 2015
A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trialMingwei Zhao, Feng Zhang, Youxin Chen, et al.
Pageof 25

Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Journal of Clinical Microbiology|July 24, 2015
Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in StoolLinan Song, Mingwei Zhao, David C Duffy, et al.
BMC Ophthalmology|January 3, 2025
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centersYusheng Zhong, Xiacheng Lin, Yating Yang, et al.
The American Journal of Pathology|May 22, 2021
Human RGR Gene and Associated Features of Age-Related Macular Degeneration in Models of Retina-Choriocapillaris AtrophyXuan Bao, Zhaoxia Zhang, Yanjiang Guo, et al.
International Journal of Retina and Vitreous|June 26, 2026
Intravitreal aflibercept 8 mg in patients with neovascular age-related macular degeneration from China: 48-week results from the PULSAR trialXiaodong Sun, Hong Dai, Youxin Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2019
Toxin A-Predominant Pathogenic Clostridioides difficile: A Novel Clinical PhenotypeQianyun Lin, Nira R Pollock, Alice Banz, et al.
Investigative Ophthalmology & Visual Science|September 12, 2022
UBE3D Is Involved in Blue Light-Induced Retinal Damage by Regulating Double-Strand Break RepairNingda Xu, Yue Liu, Shanshan Nai, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|December 17, 2022
More light components and less light damage on rats' eyes: evidence for the photobiomodulation and spectral opponencyJingxin Nie, Ningda Xu, Zhizhong Chen, et al.
Frontiers in Molecular Biosciences|June 27, 2022
Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in AsiansZongyi Wang, Jiyang Tang, Enzhong Jin, et al.
The British Journal of Ophthalmology|December 25, 2025
Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trialsShuo Zhao, Miaoqin Wu, Jingxiang Zhong, et al.
JAMA Ophthalmology|January 3, 2015
A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trialMingwei Zhao, Feng Zhang, Youxin Chen, et al.
Pageof 25